Ignacio
Bernabeu Morón
Universitat de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat de Barcelona (7)
2024
-
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466
-
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
Pituitary
-
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-Related Cancer, Vol. 31, Núm. 7
2021
-
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas
Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819
2010
-
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229
2009
-
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: Its efficacy in relation to gender and previous radio therapy
European Journal of Endocrinology, Vol. 160, Núm. 4, pp. 535-542
2004
-
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA)
European Journal of Endocrinology, Vol. 151, Núm. 4, pp. 439-446